3054 logo

LIWANLI Innovation Co., Ltd. Stock Price

TWSE:3054 Community·NT$1.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3054 Share Price Performance

NT$24.00
1.50 (6.67%)
NT$24.00
1.50 (6.67%)
Price NT$24.00

3054 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

LIWANLI Innovation Co., Ltd. Key Details

NT$91.0m

Revenue

NT$66.9m

Cost of Revenue

NT$24.1m

Gross Profit

NT$49.9m

Other Expenses

-NT$25.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.32
26.45%
-28.42%
0%
View Full Analysis

About 3054

Founded
1980
Employees
n/a
CEO
n/a
WebsiteView website
www.liwanli.com.tw

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for male, female, elderly, and children. Its products include anti-aging desire, pro-active nutrients capsules, black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin sQ10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat’s milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. In addition, the company provides products in the areas of nutrition and healthcare. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.

Recent 3054 News & Updates

Recent updates

No updates